Seth P. Lerner, MD, presented “A Review of The OLYMPUS Trial: Nephron Sparing for UTUC” for the Grand Rounds in Urology audience in October 2019.
How to cite: Lerner, Seth P. “A Review of The OLYMPUS Trial: Nephron Sparing for UTUC” October, 2019. Accessed Mar 2021. https://grandroundsinurology.com/a-review-of-the-olympus-trial-nephron-sparing-for-utuc/
A Review of The OLYMPUS Trial: Nephron Sparing for UTUC -Summary:
Seth P. Lerner, MD, Professor of Urology at Baylor College of Medicine, reviews the results of the Optimized DeLivery of Mitomycin for Primary UTUC Study (OLYMPUS) trial, of which he was the principal investigator. In this study, a thermal, reversible gel was used as a kidney-sparing treatment of low-grade upper tract urothelial cancer (UTUC). He discusses the difficulty of managing UTUC, the function of UGN-101, and the dramatic results in patient outcomes from this trial.